INSIGHTS ON CLINICAL TRIAL DESIGN
-
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM
Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early.
-
Are Transportation Failures Really Logistics Problems?
Missed clinical visits stem from fragmented financial workflows — not transport. Integrating payments, approvals, and travel cuts delays, boosts participation, and keeps studies on track.
-
Decentralized Trials Still Need Connected Support
Decentralized and hybrid trials reduce travel burdens but add coordination challenges. Strong support improves communication, engagement, and smooth trial execution from enrollment to completion.
-
Early Detection vs. Overdiagnosis: The ctDNA Screening Paradox6/4/2026
Discover how ctDNA could transform early cancer detection and why the BRCA model offers important lessons for balancing innovation, risk, and meaningful patient outcomes.
-
Inspection Facilitation Without Local MAH Presence5/26/2026
Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.
-
On-site ePRO Solutions For Flexible Data Collection Across Devices3/17/2026
Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.
-
Evidence Of An Industry's Readiness To Collaborate11/13/2024
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
-
Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us7/6/2026
Benchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
-
Accelerate trial timelines and recruitment while reducing site burden through this site network solution.
-
The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.